The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays.
about
Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemiaFibroblast growth factor 23Fibrous dysplasia and fibroblast growth factor-23 regulationTumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literatureHypophosphatemic rickets: revealing novel control points for phosphate homeostasis.Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrationsEffect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study.Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.Intravenous iron administration and hypophosphatemia in clinical practice.Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models.Iron status and fibroblast growth factor-23 in Gambian children.Follow-up study of Gambian children with rickets-like bone deformities and elevated plasma FGF23: possible aetiological factorsFibroblast growth factor 23: state of the field and future directionsFGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study.Insights from genetic disorders of phosphate homeostasisThe Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program.Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.Autosomal dominant hypophosphatemic rickets in an 85 year old woman: characterization of her disease from infancy through adulthood.Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children.Hypophosphatemic rickets: unraveling the role of FGF23.Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.Relationship between vitamin D deficiency, bone remodelling and iron status in iron-deficient young women consuming an iron-fortified food.C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.Low molecular weight iron dextran increases fibroblast growth factor-23 concentration, together with parathyroid hormone decrease in hemodialyzed patients.Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus
P2860
Q26750413-1A4E6A60-5C17-41B5-A2DD-CD83C922A479Q26829294-E2D97756-AFB2-4B37-BB26-FF84D35F951BQ27010789-809BDD8F-F710-4B6A-9760-5BC554C6B2B0Q33579283-1B302307-DE01-4279-8B75-51A0C648BA6DQ34069793-7BA97FE6-24C8-40E2-BBC2-A67229E78E6CQ34650666-9B47857C-953E-49C5-90BB-5805033E8087Q34884492-FCE7427C-A07C-4EDA-BE3E-0AC5478C963AQ35067500-F2A666DC-78B5-4562-947B-C0273965AFEDQ35497877-B32E3EFE-01B9-40D6-8BAC-76DB1974E645Q35558693-D9754F38-6C7F-45E6-95D6-3CDC3B7E8F96Q35591336-A7A2192E-1E02-425C-A089-A806DDFE0456Q35755137-468496E6-9D4C-4F6A-AEB8-4E14AFE31EA4Q35987934-674539F3-030F-4901-B009-8EE9553987E0Q36282028-2E748017-9B83-4356-A28D-26A5C24F36EDQ36413230-E1D4B6D9-854A-46C8-85B7-9BECD0837D88Q36468751-9CF2F96A-F168-4D92-AC3B-BD355F5F4B7AQ36911899-9074BD5F-A03D-4097-AFE2-E76254498291Q37039758-FC2948BF-5846-490C-ADA6-9757B13FF3FFQ37106569-4F29DC5E-DABD-4530-889F-C1EA1E6CE281Q37406152-4AA0917E-02B8-4592-B674-765E08803045Q37407740-34412A55-0DCF-4DEE-AB25-AD0A76CCBD5CQ38045788-5488C54D-C4EE-4562-9D9A-2ABCA97F7DDDQ38081019-5007979B-FF50-478A-917C-EA71D603829EQ38970563-6BB019AB-798A-45F4-8766-21E163855789Q39614406-59B19648-272D-48DA-B3E2-E3A955862338Q40095461-D844B2A0-23B0-45CC-B99B-76ACCDE13040Q46248791-78D0C10F-0D1A-4BF7-A080-79A8201B6EABQ47318835-DCD6DCB6-762B-4157-A931-08D8F3848A03Q55416427-8A5AE458-4825-45C0-AA06-443AEF42EA8BQ58726402-B6CFFCE0-C560-4E97-BCAE-D6E569330488
P2860
The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The association of circulating ...... ed by three commercial assays.
@en
The association of circulating ...... ed by three commercial assays.
@nl
type
label
The association of circulating ...... ed by three commercial assays.
@en
The association of circulating ...... ed by three commercial assays.
@nl
prefLabel
The association of circulating ...... ed by three commercial assays.
@en
The association of circulating ...... ed by three commercial assays.
@nl
P2093
P1476
The association of circulating ...... ed by three commercial assays.
@en
P2093
Brian H Durham
Frank Joseph
Lisa M Bailey
William D Fraser
P304
P356
10.1258/000456307781646102
P577
2007-09-01T00:00:00Z